Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870 - Wikidata - awgldk - TriplyDB

Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870

Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870

http://www.wikidata.org/entity/Q36370598

about

Prospects for vaccine prevention of meningococcal infection Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086 Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens Meningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other Purposes Advances in structure-based vaccine design Molecular basis of host specificity in human pathogenic bacteria Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease Solution Structure of the Factor H-binding Protein, a Survival Factor and Protective Antigen of Neisseria meningitidis Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates Structure of the uncomplexedNeisseria meningitidisfactor H-binding protein fHbp (rLP2086)Structure of the C-terminal Domain of Neisseria Heparin Binding Antigen (NHBA), One of the Main Antigens of a Novel Vaccine against Neisseria meningitidis Design and Evaluation of Meningococcal Vaccines through Structure-Based Modification of Host and Pathogen Molecules Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen Protein Crystallography in Vaccine Research and Development The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement The key role of genomics in modern vaccine and drug design for emerging infectious diseases Risk of Invasive Meningococcal Disease in Men Who Have Sex with Men: Lessons Learned from an Outbreak in Germany, 2012-2013 Monoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activity Molecular epidemiology of Neisseria meningitidis serogroup B in Brazil Infections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein Characterization of MspA, an immunogenic autotransporter protein that mediates adhesion to epithelial and endothelial cells in Neisseria meningitidis.Solution structure of the immunodominant domain of protective antigen GNA1870 of Neisseria meningitidis.Emerging experience with meningococcal serogroup B protein vaccines.Recent Progress in the Prevention of Serogroup B Meningococcal Disease.Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®).A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups.Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine Inhibition of the alternative pathway of nonhuman infant complement by porin B2 contributes to virulence of Neisseria meningitidis in the infant rat model Expression of factor H binding protein of meningococcus responds to oxygen limitation through a dedicated FNR-regulated promoter.Review of meningococcal group B vaccines.Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates.Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies.The modular architecture of meningococcal factor H-binding protein.Impaired immunogenicity of a meningococcal factor H-binding protein vaccine engineered to eliminate factor h binding.Inhibition of the classical pathway of complement by meningococcal capsular polysaccharides Anti-idiotypic antibody as a potential candidate vaccine for Neisseria meningitidis serogroup B.Evaluation of recombinant lipidated P2086 protein as a vaccine candidate for group B Neisseria meningitidis in a murine nasal challenge model.Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa

P2860

Q24537338-0D1B3ADF-EAF3-47FA-94D6-39101A060337 Q24654235-44807074-B795-406E-ABE7-1668FB368EA4 Q26777382-FE040BD3-F35C-4527-9F3E-09DFC02D95AF Q26782318-9573D767-5F49-4146-8A1E-3059FFA3BA16 Q26824545-BD3AA17B-2923-4295-9C79-19CDFC89F5EE Q26864388-CB9102B0-0242-44BA-9639-3A2BC21103C4 Q26995760-55241D43-5747-4471-8003-251EE349EBAC Q27653667-549C5C49-1868-49B8-861E-1863A62B17F4 Q27653843-FD52BFCB-A565-495E-824C-3B41A4703F3F Q27667726-6FBBB07B-25C4-4268-9CBC-14A3E4F7E929 Q27674699-2EA80761-843A-4E79-AAC5-035DB46BD432 Q27675010-FCD90727-CE4C-4B37-A1D0-E3914C770256 Q27676318-EAA137F3-542E-400D-8681-FCB9B8B7C119 Q28087528-FB8E7EE4-53D2-4F13-821E-303F5E1A8689 Q28474974-CE7835DE-5CCF-4BC4-8419-59279B9965B0 Q28476274-DA7589BF-3306-4551-83BD-E404941A4563 Q28553377-769E9E9E-2CFA-4F31-8E23-F883F627F2C6 Q28730934-699584D4-01CB-4F7D-A516-B702A1179C90 Q28731309-2EF83B10-DAA9-46CB-85DE-548BF272A91B Q28972389-9C3E2969-D97F-4A93-821C-2F5DF074D054 Q30157650-B5E4D542-2EDA-4D86-BFE2-C8ACFA20D097 Q30159832-2657635E-2DC6-409C-90E9-C282CADDD7C0 Q30159962-AA246455-0999-4782-BC6A-5047A3599D96 Q30234958-00BDF73E-7385-42B0-BF1D-6E89A32D3661 Q30235040-95851118-8B89-41E7-9687-DC5CF577EF2E Q30248749-AB12C831-5939-4382-AC5A-16A9F6C964C2 Q33418169-877107FD-EF9A-4E91-8C4C-5FFAF32FD31B Q33600936-04CD997A-1856-4B48-9F01-8A66DBCDD225 Q33602953-C62A000C-A0A7-4F7A-8AD7-7C204511B3C9 Q33614888-19BCD938-3102-4D33-ABCB-474193B39DF7 Q33646965-1B45B870-E93D-40C2-B786-F23D987EE0A9 Q33695485-0697AB03-DBC3-432A-BC42-592AEF37A587 Q33703560-171FD9DC-1BCA-4A72-BC85-0ADEE2868A0A Q33792844-2738C31E-1D2E-4E17-B1D0-34F006B6781C Q33809048-407DC443-A0C2-42F6-871C-80656B446599 Q33962709-E5C76049-B6F0-4885-B63D-AF9C2B3CFCD6 Q33992223-F1967ADA-2F29-4929-8D67-C30DCD5F4A50 Q34033132-E6BD25B3-A01C-4142-8C7E-2E9971B5D4DD Q34033214-F96C5260-45F7-4CE1-94B6-BF38F1E045C1 Q34039044-4B8E80D4-A42C-4023-8183-F9F4AF8F3AEA

P2860

Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870

http://www.wikidata.org/entity/Q36370598

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Vaccination against Neisseria ...... nts of the lipoprotein GNA1870

@ast

Vaccination against Neisseria ...... nts of the lipoprotein GNA1870

@en

type

label

Vaccination against Neisseria ...... nts of the lipoprotein GNA1870

@ast

Vaccination against Neisseria ...... nts of the lipoprotein GNA1870

@en

prefLabel

Vaccination against Neisseria ...... nts of the lipoprotein GNA1870

@ast

Vaccination against Neisseria ...... nts of the lipoprotein GNA1870

@en

P1433

Q36370598-E1BD973A-4DA8-4423-83F5-00F54ED81A74

P1476

Q36370598-D0225016-9BF5-4300-9A96-4EA4C2BD47FE

P2093

Q36370598-0D6874A3-9081-483A-BD08-F99FDF2B4E4E

Q36370598-0F7E2802-2575-4DCD-8EDF-EAD3B6FCE8AD

Q36370598-15F2AE83-4A94-4D1D-8007-1BD297D10CF3

Q36370598-1FCEFB76-95E0-4C82-9B23-C270321634AC

Q36370598-29E3E72E-CD1F-44B5-BE53-587B1A1C463E

Q36370598-412EFF62-3945-4700-AFEA-0856EBA5E907

Q36370598-48A6E00E-7CFB-4B75-B776-6B77AFCC7A5D

Q36370598-625CD153-5B3F-4776-A1B2-4E7BD1ECFE22

Q36370598-723B9F0E-BDB7-4C7B-A992-81040289E7A3

Q36370598-7B487A60-12A8-4E34-8A64-397C1F8F2C9F

P2860

Q36370598-1984415A-B6EA-4EFE-80B8-40AE85EE0A93

Q36370598-1F15A519-93F7-43C7-8189-3158BBF3EA2B

Q36370598-2BCDA040-326A-45FC-A53D-472941447C18

Q36370598-32442896-5283-4DE1-A906-34024383944F

Q36370598-32F98B20-8E9D-49D5-9355-9E11F90C1037

Q36370598-357CB55F-F061-4B95-AF25-065670D7EAFB

Q36370598-38643774-A685-4E1D-A3E8-7B481F42E881

Q36370598-40794D05-68A7-4140-8C9E-4D432AF815B1

Q36370598-44219EB8-08D1-4013-9966-5B5429702313

Q36370598-572942E9-E2B7-43FF-BDA8-A085B2DA1561

P304

Q36370598-6847BDDE-516A-4285-A0CE-5A01A5FFFEE2

P31

Q36370598-0501A841-4874-4135-832D-286B0FF5A813

P356

Q36370598-E3D93554-70D9-4FC1-916A-FF7C1DBE1229

P407

Q36370598-A72820D5-0E27-4992-B0F7-84FA529A4BB3

P433

Q36370598-E89DAB8F-3A0F-4B7F-A049-BD22E737A0AE

P478

Q36370598-188BD4AD-1F94-43D5-B39D-C0DA6D964E8C

P50

Q36370598-67956B3C-776D-4F23-A4D1-4C2576D20FA2

P577

Q36370598-8320ADFF-E100-4D88-8F95-A39FC83D4C55

P5875

Q36370598-CE06F919-D9FC-4578-92D6-CAF153CE96B6

P698

Q36370598-6705FF8A-42F7-466F-A41B-CAD1BA9F0600

P921

Q36370598-39C12A59-E64A-44A9-ABB1-5A095A1680D9

Q36370598-E3914C4A-6CBE-4C67-954B-894774D5BF4F

P932

Q36370598-755DFE01-97BE-4A02-B558-BF6481428331

P356

P1433

Journal of Experimental Medicine

P1476

Vaccination against Neisseria ...... nts of the lipoprotein GNA1870

@en

P2093

Alessandro Pieri

http://www.w3.org/2001/XMLSchema#string

Beatrice Arico

http://www.w3.org/2001/XMLSchema#string

Brunella Brunelli

http://www.w3.org/2001/XMLSchema#string

Dan M Granoff

http://www.w3.org/2001/XMLSchema#string

David Litt

http://www.w3.org/2001/XMLSchema#string

Davide Serruto

http://www.w3.org/2001/XMLSchema#string

Jeannette Adu-Bobie

http://www.w3.org/2001/XMLSchema#string

Jo Anne Welsch

http://www.w3.org/2001/XMLSchema#string

Laura Santini

http://www.w3.org/2001/XMLSchema#string

Mariagrazia Pizza

http://www.w3.org/2001/XMLSchema#string

P2860

Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58

Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491

NadA, a novel vaccine candidate of Neisseria meningitidis

Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Expert system for predicting protein localization sites in gram-negative bacteria

Population genetics and molecular epidemiology of Neisseria meningitidis.

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

Autotransported serine protease A of Neisseria meningitidis: an immunogenic, surface-exposed outer membrane, and secreted protein.

Age-related disparity in functional activities of human group C serum anticapsular antibodies elicited by meningococcal polysaccharide vaccine.

P304

789-799

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20021911

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

197

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10850607

http://www.w3.org/2001/XMLSchema#string

P698

12642606

http://www.w3.org/2001/XMLSchema#string

P921

Neisseria meningitidis

P932

2193853

http://www.w3.org/2001/XMLSchema#string